# Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

> **NCT00389077** · PHASE2 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 558 (actual)

## Conditions studied

- Tumors
- Lymphomas

## Interventions

- **DRUG:** Perifosine

## Key facts

- **NCT ID:** NCT00389077
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-09
- **Target enrollment:** 558 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389077, "Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00389077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*